Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |